COCP Annual Retained Earnings
-$315.91 M
-$17.98 M-6.04%
31 December 2023
Summary:
As of January 22, 2025, COCP annual retained earnings is -$315.91 million, with the most recent change of -$17.98 million (-6.04%) on December 31, 2023. During the last 3 years, it has fallen by -$71.01 million (-28.99%). COCP annual retained earnings is now -512747.40% below its all-time high of -$61.60 thousand, reached on December 31, 2007.COCP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COCP Quarterly Retained Earnings
-$330.15 M
-$4.94 M-1.52%
30 September 2024
Summary:
As of January 22, 2025, COCP quarterly retained earnings is -$330.15 million, with the most recent change of -$4.94 million (-1.52%) on September 30, 2024. Over the past year, it has dropped by -$18.70 million (-6.00%). COCP quarterly retained earnings is now -535861.04% below its all-time high of -$61.60 thousand, reached on December 31, 2007.COCP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COCP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | -6.0% |
| 3 y3 years | -29.0% | -10.8% |
| 5 y5 years | -68.9% | -10.8% |
COCP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.9% | at low | -27.4% | at low |
| 5 y | 5-year | -34.3% | at low | -40.3% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Cocrystal Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$330.15 M(+1.5%) |
| June 2024 | - | -$325.21 M(+1.7%) |
| Mar 2024 | - | -$319.87 M(+1.3%) |
| Dec 2023 | -$315.91 M(+6.0%) | -$315.91 M(+1.4%) |
| Sept 2023 | - | -$311.45 M(+1.4%) |
| June 2023 | - | -$307.29 M(+1.4%) |
| Mar 2023 | - | -$303.12 M(+1.7%) |
| Dec 2022 | -$297.93 M(+15.0%) | -$297.93 M(+1.5%) |
| Sept 2022 | - | -$293.43 M(+2.0%) |
| June 2022 | - | -$287.73 M(+9.3%) |
| Mar 2022 | - | -$263.30 M(+1.6%) |
| Dec 2021 | -$259.09 M(+5.8%) | -$259.09 M(+1.4%) |
| Sept 2021 | - | -$255.41 M(+1.6%) |
| June 2021 | - | -$251.47 M(+1.5%) |
| Mar 2021 | - | -$247.65 M(+1.1%) |
| Dec 2020 | -$244.91 M(+4.1%) | -$244.91 M(+0.6%) |
| Sept 2020 | - | -$243.41 M(+1.1%) |
| June 2020 | - | -$240.75 M(+1.5%) |
| Mar 2020 | - | -$237.25 M(+0.8%) |
| Dec 2019 | -$235.26 M(+25.7%) | -$235.26 M(+25.5%) |
| Sept 2019 | - | -$187.41 M(+1.0%) |
| June 2019 | - | -$185.63 M(+0.8%) |
| Mar 2019 | - | -$184.12 M(-1.6%) |
| Dec 2018 | -$187.09 M(+35.5%) | -$187.09 M(+31.0%) |
| Sept 2018 | - | -$142.81 M(+1.3%) |
| June 2018 | - | -$140.94 M(+1.0%) |
| Mar 2018 | - | -$139.60 M(+1.1%) |
| Dec 2017 | -$138.04 M(+0.4%) | -$138.04 M(-3.6%) |
| Sept 2017 | - | -$143.24 M(+1.6%) |
| June 2017 | - | -$140.98 M(+0.7%) |
| Mar 2017 | - | -$139.98 M(+1.9%) |
| Dec 2016 | -$137.43 M | -$137.43 M(+91.7%) |
| Sept 2016 | - | -$71.68 M(+2.7%) |
| June 2016 | - | -$69.80 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | -$66.57 M(+6.4%) |
| Dec 2015 | -$62.56 M(+403.1%) | -$62.56 M(+94.8%) |
| Sept 2015 | - | -$32.11 M(+1.6%) |
| June 2015 | - | -$31.60 M(+9.1%) |
| Mar 2015 | - | -$28.98 M(+133.0%) |
| Dec 2014 | -$12.43 M(+0.8%) | -$12.43 M(+18.1%) |
| Sept 2014 | - | -$10.53 M(+32.0%) |
| June 2014 | - | -$7.98 M(-37.2%) |
| Mar 2014 | - | -$12.71 M(+3.0%) |
| Dec 2013 | -$12.34 M(-12.7%) | -$12.34 M(-43.0%) |
| Sept 2013 | - | -$21.66 M(+32.5%) |
| June 2013 | - | -$16.35 M(+4.8%) |
| Mar 2013 | - | -$15.60 M(+10.4%) |
| Dec 2012 | -$14.13 M(+129.2%) | -$14.13 M(+33.0%) |
| Sept 2012 | - | -$10.62 M(-39.0%) |
| June 2012 | - | -$17.41 M(+77.5%) |
| Mar 2012 | - | -$9.81 M(+59.2%) |
| Dec 2011 | -$6.16 M(+772.8%) | -$6.16 M(+40.9%) |
| Sept 2011 | - | -$4.37 M(+115.1%) |
| June 2011 | - | -$2.03 M(+873.9%) |
| Mar 2011 | - | -$208.70 K(-70.4%) |
| Dec 2010 | -$706.20 K(+353.0%) | -$706.20 K(+260.9%) |
| Sept 2010 | - | -$195.70 K(+9.0%) |
| June 2010 | - | -$179.50 K(+12.8%) |
| Mar 2010 | - | -$159.20 K(+2.1%) |
| Dec 2009 | -$155.90 K(+36.2%) | -$155.90 K(+7.4%) |
| Sept 2009 | - | -$145.20 K(+4.5%) |
| June 2009 | - | -$139.00 K(+5.5%) |
| Mar 2009 | - | -$131.70 K(+15.0%) |
| Dec 2008 | -$114.50 K(+85.9%) | -$114.50 K(+8.1%) |
| Sept 2008 | - | -$105.90 K(+9.1%) |
| June 2008 | - | -$97.10 K(+17.4%) |
| Mar 2008 | - | -$82.70 K(+34.3%) |
| Dec 2007 | -$61.60 K | -$61.60 K |
FAQ
- What is Cocrystal Pharma annual retained earnings?
- What is the all time high annual retained earnings for Cocrystal Pharma?
- What is Cocrystal Pharma annual retained earnings year-on-year change?
- What is Cocrystal Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly retained earnings year-on-year change?
What is Cocrystal Pharma annual retained earnings?
The current annual retained earnings of COCP is -$315.91 M
What is the all time high annual retained earnings for Cocrystal Pharma?
Cocrystal Pharma all-time high annual retained earnings is -$61.60 K
What is Cocrystal Pharma annual retained earnings year-on-year change?
Over the past year, COCP annual retained earnings has changed by -$17.98 M (-6.04%)
What is Cocrystal Pharma quarterly retained earnings?
The current quarterly retained earnings of COCP is -$330.15 M
What is the all time high quarterly retained earnings for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly retained earnings is -$61.60 K
What is Cocrystal Pharma quarterly retained earnings year-on-year change?
Over the past year, COCP quarterly retained earnings has changed by -$18.70 M (-6.00%)